Coliseo

Head-to-Head Startup Ranking & Discovery

S

Sensible Biotechnologies

Bio · Europe · Early-stage

sensible.bio ↗

The future of mRNA therapeutics is hampered by manufacturing challenges and unless solved, its exciting potential may never be realised. Sensible enables the next generation of mRNA medicines by turning living cells into factories producing abundant, highly stable and non-immunogenic mRNA in a scalable and cost-effective way.

Ratings are live Elo scores from head-to-head crowd votes — opinion, not fact or financial advice. How it works →